Literature DB >> 21117953

Optimization of high-resolution melting analysis for simultaneous genotyping of two 11β-hydroxysteroid dehydrogenase type 1 gene polymorphisms.

Tanja Dujic1, Barbara Ostanek, Janja Marc, Adlija Causevic, Barbara Mlinar.   

Abstract

BACKGROUND: Polymorphisms in HSD11B1, the gene encoding 11β-hydroxysteroid dehydrogenase type 1 enzyme, have been associated with obesity, metabolic syndrome, and type 2 diabetes. In this study, we present an optimized high-resolution melting (HRM) method for genotyping two common polymorphisms of the HSD11B1 gene: rs846910: G>A and rs45487298: insA.
METHODS: One hundred DNA samples from patients with polycystic ovary syndrome and healthy controls were genotyped by HRM. The results were compared with those obtained with classic polymerase chain reaction followed by restriction fragment length polymorphism analysis.
RESULTS: Various approaches were used during HRM specificity optimization. With the optimized method, genotyping accuracy of 100% was achieved.
CONCLUSIONS: HRM analysis is a fast, simple, and cost-effective method compared with the alternative genotyping approaches. The work required for optimizing the method (improvement of specificity) is minor compared to the advantages.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21117953     DOI: 10.1089/gtmb.2010.0105

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  2 in total

1.  Real-time RT-PCR high-resolution melting curve analysis and multiplex RT-PCR to detect and differentiate grapevine leafroll-associated virus 3 variant groups I, II, III and VI.

Authors:  Rachelle Bester; Anna E C Jooste; Hans J Maree; Johan T Burger
Journal:  Virol J       Date:  2012-09-27       Impact factor: 4.099

2.  Association between 11beta-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome in Bosnian population.

Authors:  Tanja Dujic; Tamer Bego; Barbara Mlinar; Sabina Semiz; Maja Malenica; Besim Prnjavorac; Barbara Ostanek; Janja Marc; Adlija Causevic
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.